Diaceutics (DIUXF) Stock Statistics & Valuation Metrics

Diaceutics has a market cap or net worth of $137.62M. The enterprise value is $90.95M.

Diaceutics has 84,812,640 shares outstanding. The number of shares has decreased by -2.65% in one year.

Diaceutics’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.34%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Diaceutics had revenue of 32.16M and earned -1.70M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was 1.00M and capital expenditures -100.00K, giving a free cash flow of 900.00K billion.

Diaceutics pays an annual dividend of ―, resulting in a dividend yield of ―

Diaceutics upcoming earnings date is Sep 16, 2025, Before Open (Confirmed).

Diaceutics as a current ratio of 3.80, with Debt / Equity ratio of 2.66%

In the past 12 months, Diaceutics has paid -205.00K in taxes.

Diaceutics EV to EBITDA ratio is 34.01, with an EV/FCF ratio of -23.69.

Diaceutics has $12.74M in cash and marketable securities with £1.06M in debt, giving a net cash position of -$11.68M billion.

Gross margin is 81.32%, with operating margin of -7.63%, and net profit margin of -5.30%.

The average price target for Diaceutics is $2.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy